Financials data is unavailable for this security.
View more
Year on year VG Life Sciences Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 7.42m to a smaller loss of 6.19m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -384.41% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2014, cash reserves at VG Life Sciences Inc fell by 679.90k. Cash Flow from Financing totalled 1.23m or -- of revenues. In addition the company used 1.91m for operations while cash from investing was breakeven.
| Cash flow per share | -0.0071 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0491 |
|---|---|
| Tangible book value per share | -0.0597 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.0074 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
